Max Jonson
Fortuna: 380 316 $ al 31/05/2026
Fortuna: 380 316 $ al 31/05/2026
Max Jonson is currently Director at BioLamina AB, Bure Growth AB, and Skanditek AB. Mr. Jonson is Chief Financial Officer at Bure Equity AB and Bure Equity since 2013.
Former roles include Director at Celemiab Group AB (2014–2016), Dipylon Medical AB (2016–2017), Atle Investment Management AB, and Celemi International AB (2016–2018).
Mr. Jonson was Associate Director-Corporate Finance at SEB Group (Sweden) from 1996 to 2003.
Other former positions include Chief Financial Officer at Orasolv AB (2011–2012), Stockholm School of Economics Ifl (2012–2013), Sse Executive Education (2012–2013), and ACQ Bure AB. Mr. Jonson was Finance Manager at Dpnova AB (2011–2013) and held a Chief Financial Officer role at Yubico AB. Education includes an MBA from The University of Chicago and undergraduate studies at New York University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BURE EQUITY AB 0,02 % | 01/06/2026 | 12.760 ( 0,02 % ) | 380 316 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BURE EQUITY AB | Director Financiero/CFO | 01/10/2013 |
Skanditek AB | Director/Miembro de la Junta | - |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Director/Miembro de la Junta | - |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Provides investment services | Director/Miembro de la Junta | - |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions. | Director Financiero/CFO | 01/09/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
Celemi International AB | Director/Miembro de la Junta | 01/01/2018 |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments | Director/Miembro de la Junta | 01/01/2017 |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services | Director/Miembro de la Junta | 01/01/2016 |
Sse Executive Education | Director Financiero/CFO | 01/01/2013 |
| ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 18 |
|---|---|
Bure Equity AB
Bure Equity AB Financial ConglomeratesFinance Provides equity and investment services | Finance |
Orasolv AB
Orasolv AB Medical/Nursing ServicesHealth Services Engages in the provision of dental care and acquisition of companies in the dental industry | Health Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services | Commercial Services |
Dpnova AB
Dpnova AB Medical/Nursing ServicesHealth Services Develops and manufactures dental implants | Health Services |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments | Health Technology |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Health Technology |
Stockholm School of Economics Ifl
Stockholm School of Economics Ifl Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atle Investment Management AB | |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Provides investment services | Finance |
Celemi International AB | |
SEB Group (Sweden) | |
ACQ Bure AB
ACQ Bure AB Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
Skanditek AB | |
Sse Executive Education | |
Yubico AB
Yubico AB Electronics DistributorsDistribution Services Wholesales computers and software | Distribution Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.